Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
72.45
+0.30 (0.42%)
Sep 9, 2025, 4:00 PM - Market closed
Claritev Revenue
Claritev had revenue of $241.57M in the quarter ending June 30, 2025, with 3.47% growth. This brings the company's revenue in the last twelve months to $935.54M, down -2.03% year-over-year. In the year 2024, Claritev had annual revenue of $930.62M, down -3.21%.
Revenue (ttm)
$935.54M
Revenue Growth
-2.03%
P/S Ratio
1.26
Revenue / Employee
$346,496
Employees
2,700
Market Cap
1.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 930.62M | -30.90M | -3.21% |
| Dec 31, 2023 | 961.52M | -118.19M | -10.95% |
| Dec 31, 2022 | 1.08B | -37.89M | -3.39% |
| Dec 31, 2021 | 1.12B | 179.84M | 19.18% |
| Dec 31, 2020 | 937.76M | -45.14M | -4.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CTEV News
- 13 hours ago - Claritev Corporation (CTEV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - Claritev Corporation Announces Participation at Upcoming Conferences - Business Wire
- 5 weeks ago - Claritev Corporation Reports Second Quarter 2025 Results - Business Wire
- 7 weeks ago - Claritev Joins athenahealth's Marketplace Program to Empower Providers with Price Intelligence for Stronger Financial Outcomes - Business Wire
- 7 weeks ago - Claritev Releases 2024 Corporate Responsibility Report - Business Wire
- 2 months ago - Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call - Business Wire
- 2 months ago - Claritev's PHCS Network Receives Twelfth Consecutive NCQA Accreditation in Credentialing - Business Wire
- 2 months ago - Fractional AI Announces Strategic Collaboration to Accelerate Claritev's Generative AI Strategy - Business Wire